Market Place
Sourcing Support
Accent Therapeutics Announces FDA Clearance For ATX-559 IND
24 Oct 2024 //
PR NEWSWIRE
Accent Presents Data Supporting Two Lead Programs at AACR 2024 Annual Meeting
08 Apr 2024 //
PR NEWSWIRE
Accent to Present Data DHX9 and KIF18A as Compelling Therapeutic Targets at AACR
21 Mar 2024 //
PR NEWSWIRE
Accent Therapeutics Announces $75 Million Series C Financing
23 Jan 2024 //
PR NEWSWIRE
Two more pharmas invest in Accent, joining $75M series C round
23 Jan 2024 //
FIERCE BIOTECH
Accent Therapeutics Unveils XRN1 Program
10 Oct 2023 //
PR NEWSWIRE
Accent Therapeutics Bolsters Leadership Team with Key Executive Hires
21 Sep 2023 //
PR NEWSWIRE
Accent Therapeutics to Present Data Supporting DHX9 Inhibition at AACR Meeting
06 Apr 2023 //
PR NEWSWIRE
Langer, Ciechanover godfather the latest AI upstart; & more
18 Oct 2021 //
ENDPTS
Accent Appoints Julie Hambleton to its Board of Directors
25 Sep 2020 //
BUSINESSWIRE
Accent, AstraZeneca take aim at RNA modifiers in $55M pact
04 Jun 2020 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.